Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
'Mad' Marjorie Taylor Greene meltdown tied to Trump snub by MSNBC host
18/05/2024
'Sometimes the bully has to be smacked in the mouth' : MSNBC guest applauds MTG pushback
18/05/2024
Trump lawyer Blanche under the gun to recover from 'rookie mistakes' before it's too late
18/05/2024
Trump campaign faced with 'startling weakness' in scramble for cash : report
18/05/2024
Judge Cannon buried by ex-CIA official for 'indefensible' Trump stolen docs case stalling
18/05/2024
'Stay tuned' : Trump lawyers could be headed for a new gag order showdown on Monday
18/05/2024
